Clinical Trial Detail

NCT ID NCT03735628
Title An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors Bayer
Indications

hepatocellular carcinoma

Advanced Solid Tumor

colorectal cancer

non-small cell lung carcinoma

head and neck squamous cell carcinoma

Therapies

Copanlisib + Nivolumab

Age Groups: adult senior

Additional content available in CKB BOOST